N Brock

3.1k total citations
76 papers, 2.2k citations indexed

About

N Brock is a scholar working on Pathology and Forensic Medicine, Organic Chemistry and Molecular Biology. According to data from OpenAlex, N Brock has authored 76 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 13 papers in Organic Chemistry and 10 papers in Molecular Biology. Recurrent topics in N Brock's work include Chemotherapy-induced organ toxicity mitigation (15 papers), Chemical Reactions and Isotopes (8 papers) and Synthesis and biological activity (7 papers). N Brock is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (15 papers), Chemical Reactions and Isotopes (8 papers) and Synthesis and biological activity (7 papers). N Brock collaborates with scholars based in Germany, Netherlands and Russia. N Brock's co-authors include Jurij Stekar, Jörg Pohl, H. J. Hohorst, J. Pohl, Herbert Arnold, Hohorst Hj, W Scheef, H. O. Klein, Ulf Niemeyer and B Schneider and has published in prestigious journals such as Nature, Science and Cancer.

In The Last Decade

N Brock

74 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N Brock Germany	26	764	536	509	357	243	76	2.2k
Michael Colvin United States	29	403 0.5×	977 1.8×	834 1.6×	275 0.8×	381 1.6×	67	2.5k
Frederick S. Philips United States	30	177 0.2×	1.1k 2.0×	579 1.1×	253 0.7×	320 1.3×	71	2.6k
Vincent T. Oliverio United States	23	204 0.3×	712 1.3×	551 1.1×	475 1.3×	114 0.5×	49	2.1k
Robert B. Brundrett United States	18	190 0.2×	509 0.9×	348 0.7×	195 0.5×	149 0.6×	27	1.5k
Josephia R. Muindi United States	36	929 1.2×	1.8k 3.4×	652 1.3×	161 0.5×	169 0.7×	60	3.3k
Susan M. Ludeman United States	20	226 0.3×	593 1.1×	387 0.8×	215 0.6×	264 1.1×	51	1.4k
John S. Kovach United States	31	211 0.3×	1.2k 2.3×	805 1.6×	85 0.2×	315 1.3×	75	2.6k
L. G. Israels Canada	27	170 0.2×	686 1.3×	280 0.6×	109 0.3×	80 0.3×	82	1.9k
Alain Gouyette France	32	189 0.2×	1.8k 3.3×	1.2k 2.4×	190 0.5×	288 1.2×	105	3.2k
Jurij Stekar Germany	14	307 0.4×	400 0.7×	263 0.5×	130 0.4×	91 0.4×	25	1.0k

Countries citing papers authored by N Brock

Since Specialization

Citations

This map shows the geographic impact of N Brock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Brock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Brock more than expected).

Fields of papers citing papers by N Brock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N Brock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Brock. The network helps show where N Brock may publish in the future.

Co-authorship network of co-authors of N Brock

This figure shows the co-authorship network connecting the top 25 collaborators of N Brock. A scholar is included among the top collaborators of N Brock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N Brock. N Brock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brock, N. (1996). The history of the oxazaphosphorine cytostatics. Cancer. 78(3). 542–547. 28 indexed citations

Brock, N, et al.. (1989). Experimental investigations into the carcinogenic effect of antitumor and immunosuppressive agents. Journal of Cancer Research and Clinical Oncology. 115(4). 309–328. 2 indexed citations

Brock, N. (1989). Oxazaphosphorine cytostatics: past-present-future. Seventh Cain Memorial Award lecture.. PubMed. 49(1). 1–7. 93 indexed citations

Brock, N, et al.. (1988). Treatment of advanced malignancies with ifosfamide under protection with mesna.. PubMed. 8(1). 55–67. 1 indexed citations

Gurtoo, Hira L., et al.. (1988). Basis and New Developments in the Field of Oxazaphosphorines. Cancer Investigation. 6(5). 513–532. 20 indexed citations

Themann, H., et al.. (1987). Electron Microscopic Investigations of the Cyclophosphamide-Induced Lesions of the Urinary Bladder of the Rat and Their Prevention by Mesna. Urologia Internationalis. 42(1). 37–43. 20 indexed citations

Przybylski, Michael, et al.. (1985). Identification and quantification of metabolite conjugates of activated cyclophosphamide and ifosfamide with mesna in urine by ion-pair extraction and fast atom bombardment mass spectrometry. Journal of Mass Spectrometry. 12(9). 545–553. 23 indexed citations

Brock, N & Berthold Schneider. (1984). Special contributed article. Models in cytostatic chemotherapy. Cancer. 54(S1). 1229–1238. 1 indexed citations

Brock, N, P. Hilgard, J. Pohl, Kari Ormstad, & Sten Orrenius. (1984). Pharmacokinetics and mechanism of action of detoxifying low-molecular-weight thiols. Journal of Cancer Research and Clinical Oncology. 108(1). 87–97. 42 indexed citations

10.

Kunze, E., et al.. (1983). [Autoradiographic studies on the protective effect of mesna in the urinary bladder mucosa of the rat during administration of cyclophosphamide (preliminary communication)].. PubMed. 33(6). 853–4. 1 indexed citations

11.

Klein, H. O., et al.. (1983). High-dose ifosfamide and mesna as continuous infusion over five days—a phase I/II trial. Cancer Treatment Reviews. 10. 167–173. 63 indexed citations

12.

Brock, N, et al.. (1981). Pharmacological and toxicological properties of azelastine, a novel antiallergic agent.. PubMed. 31(8). 1184–93. 65 indexed citations

13.

Pohl, J., et al.. (1981). [Pharmacokinetics of Uromitexan].. PubMed. 3 Suppl 1. 95S–101S. 6 indexed citations

14.

Schnitker, J, et al.. (1976). Evaluation of a cooperative clinical study of the cytostatic agent ifosfamide.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 26(10). 1783–92. 25 indexed citations

15.

Brock, N & B Schneider. (1971). [Carcinogenic effects of anti neoplastic and immunosuppressive drugs].. PubMed. 21(4). 435–43. 2 indexed citations

16.

Brock, N, et al.. (1964). Experimenteller Beitrag zur Pr�fung teratogener Wirkungen von Arzneimitteln an der Laboratoriumsratte. Naunyn-Schmiedeberg s Archives of Pharmacology. 249(2). 117–145. 18 indexed citations

17.

Druckrey, H. & N Brock. (1960). [On the mechanism of action of stilbestrol diphosphate (honvan) in prostate carcinoma].. PubMed. 102. 1626–9. 2 indexed citations

18.

Brock, N, et al.. (1952). Beiträge zur quantitativen Auswertung von Arzneimitteln. PubMed. 215(5-6). 492–511. 1 indexed citations

19.

Brock, N, et al.. (1951). [Determination of the therapeutìc applications of drugs. On pharmacotherapy of oxyuriasis with pararosaniline derivatives II].. PubMed. 1(2). 63–72. 3 indexed citations

20.

Brock, N. (1951). Zur Pharmakologie des Avacan. DMW - Deutsche Medizinische Wochenschrift. 76(14). 474–477. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact